122 related articles for article (PubMed ID: 10941917)
1. Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill.
Liggins RT; D'Amours S; Demetrick JS; Machan LS; Burt HM
Biomaterials; 2000 Oct; 21(19):1959-69. PubMed ID: 10941917
[TBL] [Abstract][Full Text] [Related]
2. The development of a novel intraperitoneal tumor-seeding prophylactic.
Demetrick JS; Liggins RT; Machan L; Davis NL; Burt HM; Hunter WL
Am J Surg; 1997 May; 173(5):403-6. PubMed ID: 9168076
[TBL] [Abstract][Full Text] [Related]
3. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
4. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
Lu J; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers.
Liggins RT; Burt HM
Int J Pharm; 2001 Jul; 222(1):19-33. PubMed ID: 11404029
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits.
Liggins RT; Cruz T; Min W; Liang L; Hunter WL; Burt HM
Inflamm Res; 2004 Aug; 53(8):363-72. PubMed ID: 15316667
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release.
Liggins RT; Burt HM
Int J Pharm; 2004 Sep; 282(1-2):61-71. PubMed ID: 15336382
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
[TBL] [Abstract][Full Text] [Related]
9. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kinetics.
Liggins RT; Burt HM
Int J Pharm; 2004 Aug; 281(1-2):103-6. PubMed ID: 15288347
[TBL] [Abstract][Full Text] [Related]
11. Biodegradation and antitumour effect of adriamycin-containing poly(L-lactic acid) microspheres.
Ike O; Shimizu Y; Ikada Y; Watanabe S; Natsume T; Wada R; Hyon SH; Hitomi S
Biomaterials; 1991 Oct; 12(8):757-62. PubMed ID: 1799651
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
Xie M; Zhou L; Hu T; Yao M
Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
[TBL] [Abstract][Full Text] [Related]
13. Prevention of local tumor growth with paclitaxel-loaded microspheres.
Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
[TBL] [Abstract][Full Text] [Related]
14. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
[TBL] [Abstract][Full Text] [Related]
15. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
Chandy T; Rao GH; Wilson RF; Das GS
Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
[TBL] [Abstract][Full Text] [Related]
16. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid).
Burt HM; Jackson JK; Bains SK; Liggins RT; Oktaba AM; Arsenault AL; Hunter WL
Cancer Lett; 1995 Jan; 88(1):73-9. PubMed ID: 7531612
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD
Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474
[TBL] [Abstract][Full Text] [Related]
18. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis.
Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H
Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
Ruan G; Feng SS
Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
[TBL] [Abstract][Full Text] [Related]
20. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
Ciftci K; Hincal AA; Kas HS; Ercan TM; Sungur A; Guven O; Ruacan S
Pharm Dev Technol; 1997 May; 2(2):151-60. PubMed ID: 9552441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
